RT Journal Article
SR Electronic
T1 Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006348corr1
DO 10.1136/jitc-2022-006348corr1
VO 11
IS 7
YR 2023
UL http://jitc.bmj.com/content/11/7/e006348corr1.abstract